Dallas, Texas — According to state and local economic development sources Verily Life Sciences plans to invest $4,000,000.00 to build out 29,647 square feet of new space in Dallas. The company plans to occupy the new space at 2999 Olympus in Dallas, on or about July 1, 2022. According to the company website Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verilys mission is to make the worlds health data useful so that people enjoy healthier lives. We develop tools and devices to collect, organize and activate health data, and create interventions to prevent and manage disease. Verily partners with leading life sciences, medical device, and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.

To learn more about Verily Life Sciences, visit http://verily.com/

Company Contact:
Andrew Conrad, Chief Executive Officer
650-253-0000

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved